Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NIP7 pseudogene 1 (NIP7P1) is a pseudogene related to the NIP7 locus. Pseudogenes are DNA elements resembling genes, but that have lost protein-coding ability due to mutations or lack the necessary regulatory elements. Pseudogenes may be transcriptionally active and in some cases can regulate gene expression via RNA-mediated mechanisms (such as miRNA competition or acting as decoys), but there is no evidence that NIP7P1 encodes a functional protein or plays a direct therapeutic role. NIP7P1 is not considered a validated therapeutic target, receptor, enzyme, or actionable molecule in drug development. Clarification: If the therapeutic target of interest is the NIP7 protein-coding gene (not the pseudogene), refer to "Nucleolar pre-rRNA processing protein NIP7," which is involved in ribosome biogenesis and cell proliferation. However, "NIP7 pseudogene 1" itself is not a receptor, enzyme, or protein target; it is a non-coding sequence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NIP7 pseudogene 1 (NIP7P1).